#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12562	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2126	586.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1782	1782	T	692	T,C	647,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12562	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2126	586.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1516	1516	C	714	C,T	656,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22632	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3715	607.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1717	1717	A	730	A,C	683,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22632	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3715	607.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2351	2351	C	713	C,T,A	668,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22632	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3715	607.6	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2977	2977	T	726	T,C	686,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22632	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3715	607.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2425	2425	A	734	A	689	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	G5V	NONSYN	13	15	GGT	331	333	GTT	91;92;92	G;T;T	89;89;90	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	E12K	NONSYN	34	36	GAA	352	354	AAA	101;101;104	A,G,T;A;A	93,2,1;96;99	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	F31L	NONSYN	91	93	TTT	409	411	TTG	125;129;129	T;T;G,T	117;120;121,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	442	444	CAA	156;156;155	C;A;A	148;145;146	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	S75P	NONSYN	223	225	TCC	541	543	CCT	149;151;153	C;C;T	140;141;148	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	V87A	NONSYN	259	261	GTA	577	579	GCA	142;139;138	G;C;A,G	137;133;132,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	V130L	NONSYN	388	390	GTC	706	708	CTC	192;194;194	C;T;C	180;180;182	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	R135C	NONSYN	403	405	CGC	721	723	TGT	193;195;192	T;G;T	175;182;175	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	T137A	NONSYN	409	411	ACG	727	729	GCG	190;190;194	G;C;G	183;176;183	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	769	771	AAG	164;169;166	A;A;G	157;163;160	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	772	774	AAT	166;165;164	A;A;T	159;159;157	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	F218L	NONSYN	652	654	TTT	970	972	TTG	109;110;107	T;T;G	107;106;103	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1000	1002	AGC	102;102;102	A;G;C	98;97;97	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1069	1071	CTG	79;80;78	C,T;T;G	70,2;71;67	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1075	1077	TCC	79;79;78	T;C;C	74;72;74	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1090	1092	GTG	88;90;89	G;T,C;G	81;79,1;82	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1382	folP	852	852	93.78	folP.l15.c4.ctg.1	1486	92.5	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1141	1143	GCG	116;112;109	G;C;G	111;106;103	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4520	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3413	132.0	1	SNP	p	S91F	0	.	.	271	273	TCC	623	625	TCC	151;152;154	T;C;C,A	139;141;141,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4520	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3413	132.0	1	SNP	p	D95N	0	.	.	283	285	GAC	635	637	GAC	151;154;154	G;A;C	138;136;137	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4520	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3413	132.0	1	SNP	p	D95G	0	.	.	283	285	GAC	635	637	GAC	151;154;154	G;A;C	138;136;137	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	531	1562	mtrR	633	633	99.68	mtrR.l15.c17.ctg.1	1338	116.2	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	718	718	T	198	T,C	188,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	796	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1231	64.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1568	1570	ATC	173;175;173	A;T,C;C	162;166,1;165	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1721	1723	GCA	161;162;161	G,A;C;A	144,1;143;141	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	1	SNP	p	D86N	0	.	.	256	258	GAC	674	676	GAC	182;181;181	G;A;C	170;164;169	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	1	SNP	p	S87W	0	.	.	259	261	AGT	677	679	AGT	180;179;177	A;G;T	169;168;165	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	1	SNP	p	S87R	0	.	.	259	261	AGT	677	679	AGT	180;179;177	A;G;T	169;168;165	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	1	SNP	p	S87I	0	.	.	259	261	AGT	677	679	AGT	180;179;177	A;G;T	169;168;165	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4210	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3092	135.5	1	SNP	p	S88P	0	.	.	262	264	TCC	680	682	TCC	177;176;177	T;C;C	165;163;163	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3916	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2627	148.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1469	1471	GGC	175;172;169	G;G;C	168;164;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1294	1296	GCA	180;180;182	G;C;A	169;168;169	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1297	1299	ATC	182;184;184	A;T;C	170;172;172	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1309	1311	GTG	177;179;180	G;T;G,A	164;163;165,1	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1309	1311	GTG	177;179;180	G;T;G,A	164;163;165,1	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1813	1815	ACC	153;151;153	A;C;C	134;139;143	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1867	1869	GCG	158;155;153	G;C;G	138;124;131	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1867	1869	GCG	158;155;153	G;C;G	138;124;131	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1990	1992	GGT	130;128;126	G;G;T	124;121;120	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1999	2001	GGC	115;112;111	G;G;C	109;110;109	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3194	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2398	132.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2017	2019	CCG	98;100;102	C,G;C,G;G	77,5;77,1;79	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	4100	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3208	127.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1730	1732	CTG	151;152;150	C;T;G	134;133;131	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	787	1774	porA	1146	1146	99.74	porA.l6.c30.ctg.1	1867	92.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	1426	1428	CGA	120;119;119	C;G;A	111;110;111	.	.
porA.NCCP11945	porA.NCCP11945	1	0	787	1774	porA	1146	1146	99.74	porA.l6.c30.ctg.1	1867	92.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	1243	1243	A	123	A	113	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2426	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1588	151.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	953	953	T	195	T,A	178,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2426	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1588	151.8	1	SNP	p	G120K	0	.	.	358	360	GGT	680	682	GGT	166;165;164	G;G;T	159;156;148	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2426	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1588	151.8	1	SNP	p	A121N	0	.	.	361	363	GCC	683	685	GCC	163;165;169	G;C;C	155;159;162	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2426	porB1b	1035	1035	98.66	porB1b.l15.c4.ctg.1	1588	151.8	1	SNP	p	A121D	0	.	.	361	363	GCC	683	685	GCC	163;165;169	G;C;C	155;159;162	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9396	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4803	195.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	956	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1044	90.5	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	187;185;182	A;T;G	175;174;171	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
